Completed
The ongoing COVID-19 pandemic response has demonstrated how innovative global public-private partnerships and coordination mechanisms can lead to rapid successes in viral vaccine research, manufacturing, and risk pooling. Yet, it has also exposed continued governance barriers for effective viral pandemic preparedness and response. At the request of the U.S. Department of Health and Human Services, the National Academies have convened a committee to analyze the current influenza global governance landscape and relevancy of COVID-19 innovations, and to provide actionable recommendations for strengthening global collaborations, regulations, and financing structures around influenza vaccination.
Events
The Current Global Governance Landscape for Influenza Vaccines - Meeting 1
- March 9 - 11, 2021
- Past
This first meeting of the committee, taking place virtually over three days, will serve for the committee to begin to analyze the major global frameworks, regulations, and partnerships for influenza v...
Finalizing Recommendations for Influenza Global Vaccine Coordination and Financing - Meeting 5
- July 13, 2021
- 8:00 AM - 10:00 AM (ET)
- Closed
- Meeting
- Past
During this final meeting, the committee will discuss and refine current draft recommendations. The committee will consider options for a report title, and will determine areas of the statement of tas...
Recommendations for Pandemic Influenza Vaccine Governance - Meeting 4
- June 21 - 23, 2021
- Closed
- Meeting
- Past
During this two-day closed meeting session, committee working groups will discuss their interim findings, conclusions, and recommendations. Discussions will focus on international instruments for path...
Designing Global Coordination Structures for Influenza (Meeting 3, Day 3)
- May 14, 2021
- 8:00 AM - 11:00 AM (ET)
- Closed
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Lessons Learned from Global Influenza Technology Transfer Partnerships – Meeting 3, Supplementary Session
- May 11, 2021
- 1:00 PM - 1:45 PM (ET)
- Meeting
- Past
In this short open session, the committee’s technology and manufacturing partnerships working group will hold a Question and Answer session with a speaker about lessons learned from the World Health O...
Designing Global Coordination Structures for Influenza (Meeting 3, Day 2)
- May 7, 2021
- 9:00 AM - 11:00 AM (ET)
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 2)
- May 7, 2021
- 9:00 AM - 11:00 AM (ET)
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 2)
- May 7, 2021
- 9:00 AM - 11:00 AM (ET)
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Designing Global Coordination Structures for Influenza - Pathogen Sharing Working Group (Meeting 3, Day 1)
- May 6, 2021
- 8:00 AM - 10:00 AM (ET)
- Closed
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Designing Global Coordination Structures for Influenza - Vaccine Access and Financing Working Group (Meeting 3, Day 1)
- May 6, 2021
- 8:00 AM - 10:00 AM (ET)
- Closed
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Designing Global Coordination Structures for Influenza - Technology and Manufacturing Working Group (Meeting 3, Day 1)
- May 6, 2021
- 8:00 AM - 10:00 AM (ET)
- Meeting
- Past
During this meeting, the committee will be breaking into three working groups: pathogen sharing, vaccine technology and manufacturing partnerships, and vaccine access and financing. During the first t...
Barriers to Effective Global Coordination and Financing of Influenza Vaccines (DAY 2)
- April 16, 2021
- 7:00 AM - 10:00 AM (ET)
- Meeting
- Past
The second meeting of the committee, taking place virtually over two days, will serve for the committee to analyze major barriers and gaps for effective global coordination and financing for influenza...
Barriers to Effective Global Coordination and Financing of Influenza Vaccines (DAY 1)
- April 9, 2021
- 8:00 AM - 11:00 AM (ET)
- Meeting
- Past
The second meeting of the committee, taking place virtually over two days, will serve for the committee to analyze major barriers and gaps for effective global coordination and financing for influenza...